Article
Author(s):
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
FDA Grants Approval for Kedrion Biopharma’s Primary Humoral Immunodeficiency Treatment Qivigy
Pharmaceutical Executive Daily: September 29, 2025
Novo Nordisk Resubmits Biologics License Application to FDA for Awiqli
Pharmaceutical Executive Daily: September 26, 2025
AbbVie Breaks Ground on Illinois API Manufacturing Site
Genmab Acquires Merus in $8 Billion Transaction Agreement Including Late-Stage Breakthrough Therapy Asset Petosemtamab